See also this year's filing and all EDGAR filings for this company.
PDF Report 0001358403_2023_BELLICUM_PHARMACEUTICALS_INC.pdf
Logs
Graph
Absolute values for 0001358403, BELLICUM PHARMACEUTICALS INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 23,801,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 22,000 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 3,772,000 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 5,717,000 |
9 | ResearchAndDevelopmentExpense | 22,764,000 |
10 | remainder_Expenses | 2,000 |
11 | remainder_Revenues | 1,500,000 |
12 | remainder_NetIncome | 2,010,000 |
13 | remainder_ComprehensiveNetIncome | -16,000 |
yvar | yval | |
---|---|---|
0 | Assets | 23,823,000 |
1 | Liabilities | 3,772,000 |
2 | Expenses | 28,483,000 |
3 | Revenues | 1,500,000 |
4 | StockholdersEquity | 20,051,000 |
5 | NetIncome | -24,973,000 |
6 | ComprehensiveNetIncome | -24,981,000 |
7 | BaseVar | 29,802,000 |
8 | EconomicCapitalRatio | 0.689 |